ELOX Eloxx Pharmaceuticals, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

ELOX [NASD]

Eloxx Pharmaceuticals, Inc.

Healthcare | Biotechnology | USA

statements

Index	-	P/E	-	EPS (ttm)	-1.16	Insider Own	11.18%	Shs Outstand	40.13M	Perf Week	-12.76%
Market Cap	95.76M	Forward P/E	-	EPS next Y	-0.83	Insider Trans	0.00%	Shs Float	35.66M	Perf Month	-22.63%
Income	-46.30M	PEG	-	EPS next Q	-0.20	Inst Own	52.60%	Short Float	4.06%	Perf Quarter	-16.50%
Sales	-	P/S	-	EPS this Y	8.10%	Inst Trans	0.07%	Short Ratio	17.60	Perf Half Y	29.08%
Book/sh	0.51	P/B	4.96	EPS next Y	12.60%	ROA	-86.60%	Target Price	-	Perf Year	-44.03%
Cash/sh	0.98	P/C	2.58	EPS next 5Y	-	ROE	-144.80%	52W Range	1.44 - 8.16	Perf YTD	-65.63%
Dividend	-	P/FCF	-	EPS past 5Y	44.90%	ROI	-	52W High	-67.69%	Beta	2.49
Dividend %	-	Quick Ratio	3.60	Sales past 5Y	-	Gross Margin	-	52W Low	83.12%	ATR	0.24
Employees	29	Current Ratio	3.60	Sales Q/Q	-	Oper. Margin	-	RSI (14)	42.77	Volatility	10.86% 8.51%
Optionable	Yes	Debt/Eq	0.68	EPS Q/Q	50.70%	Profit Margin	-	Rel Volume	0.42	Prev Close	2.53
Shortable	Yes	LT Debt/Eq	0.43	Earnings	Aug 06 AMC	Payout	-	Avg Volume	82.18K	Price	2.64
Recom	2.00	SMA20	-7.02%	SMA50	-12.66%	SMA200	-25.00%	Volume	26,729	Change	4.23%

Jun-11-20

Downgrade

Citigroup

Buy → Neutral

Sep-06-19

Initiated

Janney

Buy

$14

Dec-24-18

Initiated

H.C. Wainwright

Neutral

$10

Jul-03-18

Initiated

Citigroup

Buy

Sep-14-20 10:06AM	Globally Renowned Cystic Fibrosis Expert, Dr. Eitan Kerem, Joins Eloxx Pharmaceuticals as a Senior Consultant GlobeNewswire +5.07%
Aug-26-20 07:30AM	Eloxx Announces Two Preclinical Abstracts Accepted for Presentation at the 2020 North American Cystic Fibrosis Virtual Conference in October GlobeNewswire
Aug-12-20 07:30AM	Enrollment in the U.S. Phase 2 Clinical Trial in Cystic Fibrosis Has Resumed After Being Paused in Response to the COVID-19 Pandemic GlobeNewswire +8.09%
Aug-06-20 07:30AM	Eloxx Pharmaceuticals Reports Second Quarter 2020 Financial and Operating Results and Provides Business Update GlobeNewswire -6.93%
Aug-04-20 07:30AM	Eloxx Pharmaceuticals Receives U.S. Orphan Drug Designation for ELX-02 for the Treatment of Cystic Fibrosis GlobeNewswire
Jul-28-20 12:33PM	Eloxx Pharmaceuticals to Present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 13th, 2020 GlobeNewswire
Jul-21-20 02:17PM	Eloxx Pharmaceuticals to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020 GlobeNewswire
Jul-17-20 12:37PM	Do Institutions Own Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Shares? Simply Wall St.
Jul-15-20 01:08PM	Eloxx Announces Publication of Scientific Manuscript on ELX-02 in the Journal of Pharmacology and Experimental Therapeutics GlobeNewswire
Jun-18-20 11:14AM	Why Eloxx's Stock Is Trading Higher Today Benzinga +15.74%
10:42AM	Price Over Earnings Overview: Eloxx Pharmaceuticals Benzinga
Jun-17-20 04:01PM	Enrollment in Phase 2 Clinical Trial in Cystic Fibrosis Has Been Resumed in Israel and Europe After Being Paused Temporarily in Response to the COVID-19 Pandemic GlobeNewswire
Jun-11-20 12:06PM	Edited Transcript of ELOX earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents -13.41%
May-27-20 12:48PM	Hedge Funds Are Selling Eloxx Pharmaceuticals, Inc. (ELOX) Insider Monkey
May-08-20 03:01PM	Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2020 Earnings Call Transcript Motley Fool
May-07-20 04:01PM	Eloxx Pharmaceuticals Reports First Quarter 2020 Financial and Operating Results and Provides Business Update GlobeNewswire +14.12%
Apr-21-20 12:37PM	The Zacks Analyst Blog Highlights: Eloxx Pharmaceuticals, BGC Partners, SharpSpring, Ra Medical Systems and American States Water Zacks
Apr-20-20 09:24AM	5 Stocks to Gain the Most With the Economy Set to Reopen Zacks
Apr-13-20 07:30AM	Eloxx Pharmaceuticals to Report First Quarter 2020 Financial Results and Provide Business Update on May 7, 2020 GlobeNewswire -9.55%
Apr-06-20 10:53AM	Edited Transcript of ELOX earnings conference call or presentation 5-Mar-20 9:30pm GMT Thomson Reuters StreetEvents +38.46%
Mar-25-20 09:00AM	Eloxx Pharmaceuticals Provides Update on the Impact of Novel Coronavirus (COVID-19) on Phase 2 Clinical Trials in Cystic Fibrosis GlobeNewswire -16.00%
Mar-10-20 01:45PM	3 Beaten-Down Biotech Stocks With Catalysts Just Around the Corner TipRanks
Mar-05-20 04:00PM	Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial and Operating Results and Provides Business Update GlobeNewswire -9.92%
02:30PM	Eloxx Pharmaceuticals, Inc to Host Earnings Call ACCESSWIRE
Feb-26-20 04:00PM	Eloxx Strengthens its Commitment to Cystic Fibrosis Through Reallocating Resources GlobeNewswire
Jan-14-20 02:30PM	Eloxx Pharmaceuticals Provides Update on Progress of Its Phase 2 Clinical Programs for ELX-02 and ERSG Pipeline at Biotech Showcase GlobeNewswire -30.34%
Dec-27-19 06:38AM	Will Eloxx Continue to Surge Higher? Zacks
Dec-24-19 07:45AM	Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX): What Does Its Beta Value Mean For Your Portfolio? Simply Wall St. +8.15%
Dec-22-19 06:41PM	Hedge Funds Have Never Been This Bullish On Eloxx Pharmaceuticals, Inc. (ELOX) Insider Monkey
Dec-18-19 07:00AM	Eloxx Pharmaceuticals to Present at the Biotech Showcase 2020 on January 14, 2020 GlobeNewswire
Dec-11-19 05:09PM	Edited Transcript of ELOX earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Dec-06-19 07:43AM	Eloxx Pharmaceuticals, Inc. (ELOX) Shares March Higher, Can It Continue? Zacks -10.47%
Nov-19-19 07:00AM	Eloxx Pharmaceuticals to Present at the Evercore ISI 2nd Annual HealthCONx on December 4th, 2019 GlobeNewswire
Nov-18-19 07:00AM	Eloxx Pharmaceuticals to Present at the 31st Annual Piper Jaffray Healthcare Conference on December 3rd, 2019 GlobeNewswire
Nov-07-19 10:00AM	Eloxx Pharmaceuticals Presents New Positive Data for ELX-02 at the American Society of Nephrology (ASN) Kidney Week 2019 GlobeNewswire -7.20%
Nov-05-19 04:01PM	Eloxx Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results and Provides Business Update GlobeNewswire -6.89%
Oct-31-19 12:15PM	Eloxx Pharmaceuticals Presents Positive Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC) GlobeNewswire +80.18%
Oct-23-19 12:18PM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire -6.08%
Oct-10-19 08:41AM	Eloxx Pharmaceuticals to Report Third Quarter 2019 Financial Results and Provide Business Update on November 5, 2019 GlobeNewswire
Sep-23-19 07:30AM	Eloxx Pharmaceuticals Announces Cystic Fibrosis Foundation (CF Foundation) To Provide Funding and Support for ELX-02 U.S. Phase 2 Clinical Trial GlobeNewswire -9.74%
Sep-16-19 07:30AM	Eloxx Pharmaceuticals to Present at the 2019 Cantor Global Healthcare Conference on October 3rd, 2019 GlobeNewswire
Sep-13-19 07:48PM	Edited Transcript of ELOX earnings conference call or presentation 7-Aug-19 12:30pm GMT Thomson Reuters StreetEvents
Sep-10-19 07:30AM	Eloxx Pharmaceuticals to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Diseases on September 24, 2019 GlobeNewswire
Aug-26-19 09:30AM	Eloxx Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 5th, 2019 GlobeNewswire +11.52%
Aug-13-19 10:01AM	Eloxx Pharmaceuticals Announces Two Abstracts Accepted for Presentation at the American Society of Nephrology (ASN) Kidney Week 2019 GlobeNewswire
Aug-08-19 12:51PM	Eloxx Pharmaceuticals, Inc. (ELOX) Q2 2019 Earnings Call Transcript Motley Fool +5.44%
Aug-07-19 07:30AM	Eloxx Pharmaceuticals Reports Second Quarter 2019 Financial and Operating Results and Provides Business Update GlobeNewswire -9.40%
Aug-05-19 08:00AM	Eloxx Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial for ELX-02 in Cystinosis GlobeNewswire -8.40%
Jul-31-19 12:12PM	Eloxx Pharmaceuticals Announces Open Investigational New Drug Application (IND) for a Phase 2 Clinical Trial of ELX-02 in Cystic Fibrosis Patients with the G542X Mutation in the US and Protocol Endorsement from the Cystic Fibrosis Foundation (CFF) GlobeNewswire
Jul-17-19 07:30AM	Eloxx Pharmaceuticals to Present at the 39th Annual Canaccord Genuity Growth Conference on August 8th, 2019 GlobeNewswire
Jun-24-19 04:01PM	Eloxx Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire
Jun-20-19 08:36AM	Eloxx Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Stock GlobeNewswire
07:25AM	The Daily Biotech Pulse: DiaMedica Reports Positive Data For Chronic Kidney Disease Drug, Eloxx Offering, IPO Deluge Benzinga
Jun-19-19 04:01PM	Eloxx Pharmaceuticals Announces Proposed Public Offering of Common Stock GlobeNewswire -6.50%
Jun-10-19 08:00AM	Eloxx Pharmaceuticals Phase 2 Study of ELX-02 in Cystinosis Receives Authorization of Clinical Trial Application (CTA) by Health Canada and Funding from Genome Quebec and Genome Canada GlobeNewswire
Jun-06-19 04:27PM	Why Advanced Micro Devices, Ciena, and Eloxx Pharmaceuticals Jumped Today Motley Fool +10.42%
01:34PM	Eloxx Pharma Says ELX-02 Data Showed Increases In Key Metric Benzinga
12:30PM	Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 42nd European Cystic Fibrosis Society Conference (ECFS) GlobeNewswire
May-27-19 11:10AM	Investors Who Bought Eloxx Pharmaceuticals (NASDAQ:ELOX) Shares A Year Ago Are Now Down 36% Simply Wall St.
May-21-19 12:50PM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors ACCESSWIRE
May-19-19 09:29PM	Edited Transcript of ELOX earnings conference call or presentation 9-May-19 12:30pm GMT Thomson Reuters StreetEvents
May-09-19 02:50PM	Eloxx Pharmaceuticals, Inc. (ELOX) Q1 2019 Earnings Call Transcript Motley Fool +7.63%
07:00AM	Eloxx Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results and Provides Business Update GlobeNewswire
May-02-19 10:30AM	Eloxx Pharmaceuticals Presents Positive New Data at the Association for Research in Vision and Ophthalmology ARVO 2019 Annual Meeting GlobeNewswire
Apr-22-19 09:37AM	Eloxx Pharmaceuticals to Report First Quarter 2019 Financial Results and Provide Business Update on May 9, 2019 GlobeNewswire
Apr-15-19 01:15PM	Eloxx Pharmaceuticals to Participate in the 2019 5th Annual SunTrust Robinson Humphrey (STRH) Life Sciences Summit on May 7, 2019 GlobeNewswire
Apr-11-19 02:45PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Directors of Eloxx Pharmaceuticals, Inc. ACCESSWIRE
12:07PM	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Mar-27-19 09:00AM	Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the European Cystic Fibrosis Society (ECFS) Basic Science Conference GlobeNewswire
Mar-26-19 12:11PM	Proteostasis Plunges on Weak Data From Cystic Fibrosis Study Zacks
Mar-20-19 12:19PM	Eloxx Pharmaceuticals to Present at the Guggenheim Rare Disease & Genomic Medicines Day on April 2, 2019 GlobeNewswire -7.80%
Mar-12-19 11:35PM	Edited Transcript of ELOX earnings conference call or presentation 8-Mar-19 1:00pm GMT Thomson Reuters StreetEvents
Mar-08-19 11:39AM	Eloxx Pharmaceuticals, Inc. (ELOX) Q4 2018 Earnings Conference Call Transcript Motley Fool
07:00AM	Eloxx Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
Mar-05-19 09:08AM	Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019 GlobeNewswire
Feb-26-19 04:02PM	Eloxx Pharmaceuticals Announces Participation in the HIT-CF Project on Cystic Fibrosis GlobeNewswire
Feb-20-19 04:00PM	Eloxx Pharmaceuticals to Present at the Barclays Global Healthcare Conference on March 14, 2019 GlobeNewswire
Feb-19-19 07:00AM	Eloxx Pharmaceuticals to Present at the Cowen and Company 39th Annual Health Care Conference on Monday, March 11, 2019 GlobeNewswire
Feb-14-19 08:40AM	Eloxx Pharmaceuticals to Present at the 8th Annual SVB Leerink Global Healthcare Conference in New York City on Friday, March 1, 2019 GlobeNewswire +5.48%
Feb-13-19 11:12AM	Eloxx Pharmaceuticals to Report Fourth Quarter and Full Year 2018 Financial Results and Provide Business Update on March 8, 2019 GlobeNewswire
Feb-04-19 07:00AM	Eloxx Pharmaceuticals to Present at the 2019 BIO CEO and Investor Conference in New York City on Monday, February 11, 2019 GlobeNewswire
Jan-03-19 01:08PM	Eloxx Pharmaceuticals to Participate in a Panel Discussion at the BIOTECH SHOWCASE in San Francisco on Wednesday, January 9, 2019 GlobeNewswire
Dec-20-18 02:54PM	Could The Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) Ownership Structure Tell Us Something Useful? Simply Wall St. +8.96%
Dec-19-18 05:37AM	Waltham's Eloxx aims to reach cystic fibrosis patients that Vertex can't American City Business Journals
Dec-17-18 08:39PM	Edited Transcript of ELOX earnings conference call or presentation 8-Nov-18 1:30pm GMT Thomson Reuters StreetEvents
Nov-20-18 07:00AM	Eloxx Pharmaceuticals To Present at the 30th Annual Piper Jaffray Healthcare Conference on Wednesday, November 28, 2018 GlobeNewswire
Nov-19-18 07:00AM	Eloxx Pharmaceuticals To Present at the Evercore ISI HealthCONx Conference on Tuesday, November 27, 2018 GlobeNewswire
Nov-08-18 07:00AM	Eloxx Pharmaceuticals Reports Third Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire +18.73%
Oct-18-18 11:49AM	Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC) GlobeNewswire
Oct-16-18 06:16PM	Eloxx Pharmaceuticals To Report Third Quarter 2018 Financial Results and Provide Business Update On November 8, 2018 GlobeNewswire
Sep-24-18 07:00AM	Eloxx Pharmaceuticals To Present at the 8th Orphan Drugs & Rare Diseases Congress, the Oppenheimer Fall Summit, and the 2018 Cantor Global Healthcare Conference GlobeNewswire
Aug-07-18 04:01PM	Eloxx Pharmaceuticals Reports Second Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
Jul-18-18 07:30AM	Eloxx Pharmaceuticals To Present at the 38th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-17-18 07:30AM	Eloxx Pharmaceuticals To Report Second Quarter 2018 Financial Results On August 7, 2018 and Host Webcast and Conference Call GlobeNewswire
Jun-25-18 04:20PM	Eloxx Expands Leadership Team with Two Global Pharmaceutical Executives to Accelerate Growth GlobeNewswire
Jun-18-18 07:30AM	Eloxx Appoints Global Pharmaceutical Leader, Neil Belloff, Executive Vice President, General Counsel and Corporate Secretary GlobeNewswire -10.40%
Jun-11-18 07:30AM	Neovasc Announces Appointment of Steve Rubin as Chairman of the Board and General Update CNW Group +9.17%
Jun-08-18 11:00AM	Eloxx Pharmaceuticals Presents Positive New Data for Lead Investigational Drug, ELX-02, at the 41st European Cystic Fibrosis Conference (ECFS) GlobeNewswire
May-10-18 04:01PM	Eloxx Pharmaceuticals Reports First Quarter 2018 Financial and Operating Results and Provides Business Update GlobeNewswire
May-01-18 01:27PM	Eloxx Pharmaceuticals To Report First Quarter 2018 Financial Results On May 10, 2018 and Host Webcast and Conference Call GlobeNewswire +8.07%

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel ribonucleic acid modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial that focuses on the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company was founded in 2013 and is headquartered in Waltham, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Williams Gregory C.	CHIEF EXECUTIVE OFFICER	Jul 30	Option Exercise	0.00	1,875	0	8,083	Jul 31 04:10 PM
Belloff Neil S.	COO, GENERAL COUNSEL &CORP SEC	Jul 30	Option Exercise	0.00	1,563	0	6,750	Jul 31 04:10 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience